Inhibition of cysteine protease activity disturbs DNA replication and prevents mitosis in the early mitotic cell cycles of sea urchin embryos.
Recent findings suggested that the role of cysteine proteases would not be limited to protein degradation in lysosomes but would also play regulatory functions in more specific cell mechanisms. We analyzed here the role of these enzymes in the control of cell cycle during embryogenesis. The addition of the potent cysteine protease inhibitor E64d to newly fertilized sea urchin eggs disrupted cell cycle progression, affecting nuclear as well as cytoplasmic characteristic events. Monitoring BrdU incorporation in E64d treated eggs demonstrated that DNA replication is severely disturbed. Moreover, this drug treatment inhibited male histones degradation, a step that is necessary for sperm chromatin remodeling and precedes the initiation of DNA replication in control eggs. This inhibition likely explains the DNA replication disturbance and suggests that S phase initiation requires cysteine protease activity. In turn, activation of the DNA replication checkpoint could be responsible for the consecutive block of nuclear envelope breakdown (NEB). However, in sea urchin early embryos this checkpoint doesn't control the mitotic cytoplasmic events that are not tightly coupled with NEB. Thus the fact that microtubule spindle is not assembled and cyclin B-cdk1 not activated under E64d treatment more likely rely on a distinct mechanism. Immunofluorescence experiments indicated that centrosome organization was deficient in absence of cysteine protease activity. This potentially accounts for mitotic spindle disruption and for cyclin B mis-localization in E64d treated eggs. We conclude that cysteine proteases are essential to trigger S phase and to promote M phase entry in newly fertilized sea urchin eggs.
Concha
Carolina
C
CNRS UMR 7628/UPMC, Observatoire Océanologique de Banyuls, Laboratoire ARAGO, Banyuls sur Mer, France.
Monardes
Antonia
A
Even
Yasmine
Y
Morin
Violeta
V
Puchi
Marcia
M
Imschenetzky
Maria
M
Genevière
Anne Marie
AM
D000179:Acrylates / Q000494:pharmacology; D000818:Animals; D016203:CDC2 Protein Kinase / Q000378:metabolism; D002154:Calpain / Q000037:antagonists & inhibitors; D002403:Cathepsins / Q000037:antagonists & inhibitors; D002453:Cell Cycle / Q000187:drug effects*; D002467:Cell Nucleus / Q000187:drug effects; D019926:Cyclin B / Q000378:metabolism; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology*; D003593:Cytoplasm / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects*; D004625:Embryo, Nonmammalian / Q000166:cytology / Q000378:metabolism; D007930:Leucine / Q000031:analogs & derivatives* / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects*; D012617:Sea Urchins / Q000196:embryology*; D014018:Tissue Distribution
D000179:Acrylates; D019926:Cyclin B; D015853:Cysteine Proteinase Inhibitors; C100442:PD 150606; D016203:CDC2 Protein Kinase; D002403:Cathepsins; D002154:Calpain; D007930:Leucine; C108192:aloxistatin